Clinical trial
Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or…
NCT00002625 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002625 |
|---|---|
| Title | Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma |
| Official title | PHASE I STUDY OF TOPOTECAN AND THORACIC RADIATION |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Lung Cancer, Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | topotecan hydrochloride, low-LET electron therapy, low-LET photon therapy |
| Enrollment | 5 |
| Start date | Mar 1, 1995 |
| Primary completion | Apr 1, 2000 |
| Completion | Sep 1, 2000 |
| First posted | Jun 10, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: